(TheNewswire)
Vancouver, British Columbia – TheNewswire - May 31, 2023 - Lexston Life Sciences Corp. (the “Company” ) (CSE:LEXT) (OTC:LEXTF) and theoptionor amended the Dory Property Option Agreement dated forreference January 18, 2023 (the “Dory Property Option Agreement” ). Pursuant to the amendment ( “Amendment 1” ), section 3.2 of the DoryProperty Option Agreement was replaced with the following text:
“3.2 In order toexercise the Option and earn the first Fifty One Percent (51%)interest in the Property, the Optionee, within six months from thedate of the acceptance by the Exchange of this Agreement and thechange of business of the Optionee, has to:
a) pay to the Optionor Eighty FiveThousand Dollars ($85,000); and
b) issue to the Optionor a total ofTwo Hundred and Fifty Thousand (250,000) Shares.
Upon satisfaction of the conditionsset out in this Section 3.2, the Option with respect to the 51%interest in the Property shall be deemed to be exercised, and anundivided 51% right, title and interest in the Property willautomatically vest in the Optionee and the Optionor shall promptlyregister the 51% interest in the Property in the name of the Optionee,with the applicable registration fees and costs to be borne by theOptionee.”
The Dory Property Option Agreement and Amendment 1 areavailable on www.sedar.com under the profile of the Company.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal, Chief Executive Officer
Telephone: (604) 928-8913
The Canadian Securities Exchange hasnot reviewed and does not accept responsibility for the adequacy oraccuracy of the content of this news release.
Copyright (c) 2023 TheNewswire - All rights reserved.